STOCK TITAN

Vaxart (NASDAQ: VXRT) awards 78,800 RSUs and 157,400 options to director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vaxart, Inc. director James B. Breitmeyer reported receiving equity compensation in the form of common shares and stock options. He was granted 78,800 shares of Common Stock upon vesting of restricted stock units, with the underlying award vesting in three equal annual installments starting from the grant date, subject to his continued service on the Board of Directors.

He was also granted a stock option for 157,400 shares of Common Stock at an exercise price of $0.7399 per share, expiring on April 23, 2036. The option vests in three equal annual installments from the grant date, also conditioned on continued Board service. These are compensation-related awards rather than open‑market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider BREITMEYER JAMES B
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 157,400 $0.00 --
Grant/Award Common Stock 78,800 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 157,400 shares (Direct, null); Common Stock — 78,800 shares (Direct, null)
Footnotes (1)
  1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board of Directors (the "Board"). The shares subject to this option shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board.
RSU shares granted 78,800 shares Common Stock grant upon vesting of restricted stock units
Option shares granted 157,400 shares Stock Option (right to buy) granted to director
Option exercise price $0.7399 per share Conversion or exercise price of stock option grant
Option expiration April 23, 2036 Expiration date of the stock option grant
Shares held after RSU grant 78,800 shares Total common shares held following RSU transaction
Options held after grant 157,400 options Total derivative securities held following option grant
restricted stock units financial
"Grant of shares upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of 0.7399."
vesting financial
"The shares underlying the award shall vest in equal installments."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Board of Directors financial
"Subject to the reporting person's continuing service on the Board of Directors."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BREITMEYER JAMES B

(Last)(First)(Middle)
C/O VAXART, INC.
310 UTAH AVENUE, SUITE 150

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vaxart, Inc. [ VXRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/23/2026A78,800(1)A$078,800D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$0.739904/23/2026A157,400 (2)04/23/2036Common Stock157,400$0157,400D
Explanation of Responses:
1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board of Directors (the "Board").
2. The shares subject to this option shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board.
Remarks:
This Form 4 is being filed late due to delays in receiving EDGAR access codes.
/s/ Edward Berg, attorney-in-fact for James B. Breitmeyer05/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Vaxart (VXRT) director James B. Breitmeyer report in this Form 4?

James B. Breitmeyer reported receiving equity compensation from Vaxart, Inc., including common stock and stock options. The filing shows grants tied to his service on the Board of Directors, rather than any open-market buying or selling of VXRT shares.

How many Vaxart (VXRT) shares were granted to the director as restricted stock units?

The director was granted 78,800 shares of Vaxart common stock upon vesting of restricted stock units. These shares vest in three equal annual installments from the grant date, contingent on his continued service on Vaxart’s Board of Directors.

What stock option grant did Vaxart (VXRT) award to its director, and at what exercise price?

Vaxart awarded the director a stock option covering 157,400 shares of common stock at an exercise price of $0.7399 per share. The option is a compensation grant, not an open-market purchase, and provides the right to buy VXRT shares at that stated price.

What is the vesting schedule for the Vaxart (VXRT) restricted stock units and options?

Both the restricted stock units and the stock option vest in three equal annual installments. Vesting occurs on each of the first three anniversaries of the grant date, provided the reporting person continues serving on Vaxart’s Board of Directors throughout the vesting period.

When do the Vaxart (VXRT) stock options granted to the director expire?

The stock options granted to the director expire on April 23, 2036. Until that expiration date, and subject to vesting and continued Board service, the director may choose to exercise the options to purchase VXRT common shares at $0.7399 per share.

Does this Vaxart (VXRT) Form 4 reflect any open-market buying or selling by the director?

No, the Form 4 shows compensation-related equity grants, not open-market trades. The transactions are coded as awards (Code A), indicating grants of restricted stock units and stock options, rather than discretionary purchases or sales of VXRT shares on the market.